Publication | Closed Access

Resveratrol supplement inhibited the NF-κB inflammation pathway through activating AMPKα-SIRT1 pathway in mice with fatty liver

InflammationMetabolic SyndromeMedicineLiver PhysiologyImmunologyChronic InflammationResveratrol SupplementFatty Liver DiseaseAmpkα-sirt1 PathwayMetabolic SignalingPharmacologyFatty LiverCell SignalingHealth Sciences